Prime Medicine (PRME) Asset Utilization Ratio (2024 - 2026)

Prime Medicine (PRME) posted Asset Utilization Ratio of 0.01 for Q1 2026, down 0.58% on a QoQ basis from 0.01 in Q4 2025, and up 2.95% year-over-year from 0.01 in Q1 2025.

Prime Medicine (PRME) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Prime Medicine's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.01 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 2.95% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (up 2.95% YoY) and the FY2025 annual result came in at 0.01, up 19.17% from the prior year.
  • Asset Utilization Ratio was 0.01 for Q1 2026 at Prime Medicine, down from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.02 in Q3 2025 and bottomed at 0.0 in Q2 2024.
  • A 3-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2025 — Asset Utilization Ratio soared 689.54% — and 2026, when it rose 2.95%.
  • Prime Medicine's Asset Utilization Ratio stood at 0.01 in 2024, then soared by 34.49% to 0.01 in 2025, then declined by 0.58% to 0.01 in 2026.
  • Business Quant data shows PRME's Asset Utilization Ratio at 0.01 in Q1 2026, 0.01 in Q4 2025, and 0.02 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Prime Medicine 525.98 Mn 525.98 Mn - 0.01

Historic Data

Download Data
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.02
Jun 30, 2025 0.02
Mar 31, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00